PIM1-IN-8
PIM1-IN-8 is a PIM1/p65 pathway inhibitor. PIM1-IN-8 suppresses the expression of α-SMA and collagen I in activated fibroblasts and blocks TGF-β induced migration. PIM1-IN-8 alleviates pulmonary fibrosis in a Bleomycin (BLM) (HY-17565A)-induced pulmonary fibrosis mice model. PIM1-IN-8 can be used for the study of idiopathic pulmonary fibrosis (IPF).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C17H17NO4
- Molecular Weight:299.32
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
PIM1-IN-8 (Compound B6) (20-50 μM, 48 h) displays inhibitory activity in NIH-3 T3 cells induced by TGF-β (10 ng/mL) (IR = 91.2) and a high cell viability rate (VR = 99.7) in GES-1 cells[1].
PIM1-IN-8 (3.125-100 μM, 24-48 h) inhibits fibroblast activation and proliferation in NIH-3 T3 and Ges-1 cells at concentrations ≥ 50 μM[1].
PIM1-IN-8 (2.5-10 μM) significantly suppresses the expression of α-SMA and collagen I in NIH-3 T3 cells[1].
PIM1-IN-8 (2.5-10 μM, 24 h) blocks TGF-β induced migration in A549 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:NIH-3 T3 and Ges-1 cells
-
Concentration:3.125, 6.25, 12.5, 25, 50, 100 μM
-
Incubation Time:24, 48 h
-
Result:Inhibited fibroblast activation and proliferation in NIH-3 T3 and Ges-1 cells.
-
Cell Line:A549 cells
-
Concentration:2.5, 5, 10 μM
-
Incubation Time:24 h
-
Result:Blocked TGF-β induced migration in A549 cells
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Lung fibrosis was induced in male C57BL/6 mice (8-10 weeks old, 18-22 g) using Bleomycin (BLM) at a dose of 3 mg/kg.[1]
-
Dosage:10, 20, 40 mg/kg
-
Administration:i.p. daily for 14 days
-
Result:Did not show toxicity at 500 mg/kg oral administration in mice.
Alleviated lung structural damage, including alveolar space collapse, thickened alveolar septa, and substantial collagen deposition.
Inhibited the expression of collagen I and α-SMA.
Reduced the levels of P21 and P16 in the lung tissue of IPF mice treated to 0.42 and 0.65, respectively.
Reduced the levels of IL-1β, IL-6 and the phosphorylation of P65.
Increased the levels of IL-10.
Chemical Information
-
Molecular Weight 299.32
-
Formel C17H17NO4
-
SMILES
O=C(NC1=CC(C(C)=O)=C(O)C=C1OC)C2=CC=CC(C)=C2
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
PIM1-IN-8 Related Classifications
HY-175277 Related Classifications
Powered by Bioz